Pacira Biosciences Stock Price Patterns
| PCRX Stock | USD 20.54 0.45 2.24% |
Momentum 30
Sell Stretched
Oversold | Overbought |
Quarterly Earnings Growth (0.48) | EPS Estimate Next Quarter 0.861 | EPS Estimate Current Year 2.9546 | EPS Estimate Next Year 3.407 | Wall Street Target Price 29.7143 |
Using Pacira BioSciences hype-based prediction, you can estimate the value of Pacira BioSciences from the perspective of Pacira BioSciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pacira BioSciences using Pacira BioSciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pacira using crowd psychology based on the activity and movement of Pacira BioSciences' stock price.
Pacira BioSciences Short Interest
An investor who is long Pacira BioSciences may also wish to track short interest. As short interest increases, investors should be becoming more worried about Pacira BioSciences and may potentially protect profits, hedge Pacira BioSciences with its derivative instruments, or be ready for some potential downside.
200 Day MA 24.279 | Short Percent 0.2587 | Short Ratio 7.1 | Shares Short Prior Month 7.4 M | 50 Day MA 23.8244 |
Pacira BioSciences Hype to Price Pattern
Investor biases related to Pacira BioSciences' public news can be used to forecast risks associated with an investment in Pacira. The trend in average sentiment can be used to explain how an investor holding Pacira can time the market purely based on public headlines and social activities around Pacira BioSciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pacira BioSciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pacira BioSciences.
Pacira BioSciences Implied Volatility | 0.85 |
Pacira BioSciences' implied volatility exposes the market's sentiment of Pacira BioSciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pacira BioSciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pacira BioSciences stock will not fluctuate a lot when Pacira BioSciences' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Pacira BioSciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Pacira because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pacira BioSciences after-hype prediction price | USD 20.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Pacira contract
Based on the Rule 16, the options market is currently suggesting that Pacira BioSciences will have an average daily up or down price movement of about 0.0531% per day over the life of the 2026-03-20 option contract. With Pacira BioSciences trading at USD 20.54, that is roughly USD 0.0109 . If you think that the market is fully incorporating Pacira BioSciences' daily price movement you should consider acquiring Pacira BioSciences options at the current volatility level of 0.85%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Pacira BioSciences Basic Forecasting Models to cross-verify your projections. Pacira BioSciences After-Hype Price Density Analysis
As far as predicting the price of Pacira BioSciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pacira BioSciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pacira BioSciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pacira BioSciences Estimiated After-Hype Price Volatility
In the context of predicting Pacira BioSciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pacira BioSciences' historical news coverage. Pacira BioSciences' after-hype downside and upside margins for the prediction period are 17.60 and 23.56, respectively. We have considered Pacira BioSciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pacira BioSciences is not too volatile at this time. Analysis and calculation of next after-hype price of Pacira BioSciences is based on 3 months time horizon.
Pacira BioSciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Pacira BioSciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pacira BioSciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pacira BioSciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 2.98 | 0.04 | 0.00 | 22 Events / Month | 6 Events / Month | In about 22 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
20.54 | 20.58 | 0.19 |
|
Pacira BioSciences Hype Timeline
Pacira BioSciences is at this time traded for 20.54. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.0. Pacira is projected to increase in value after the next headline, with the price projected to jump to 20.58 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.19%, whereas the daily expected return is at this time at -0.08%. The volatility of related hype on Pacira BioSciences is about 59600.0%, with the expected price after the next announcement by competition of 20.54. The company reported the previous year's revenue of 700.97 M. Net Loss for the year was (99.56 M) with profit before overhead, payroll, taxes, and interest of 470.65 M. Given the investment horizon of 90 days the next projected press release will be in about 22 days. Check out Pacira BioSciences Basic Forecasting Models to cross-verify your projections.Pacira BioSciences Related Hype Analysis
Having access to credible news sources related to Pacira BioSciences' direct competition is more important than ever and may enhance your ability to predict Pacira BioSciences' future price movements. Getting to know how Pacira BioSciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pacira BioSciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRON | Cronos Group | 0.15 | 7 per month | 2.29 | 0.03 | 3.72 | (3.54) | 21.46 | |
| ANAB | AnaptysBio | (0.44) | 8 per month | 3.54 | 0.13 | 6.11 | (5.26) | 20.41 | |
| XNCR | Xencor Inc | 0.28 | 8 per month | 0.00 | (0.03) | 6.72 | (5.08) | 16.84 | |
| OCS | Oculis Holding AG | (1.23) | 9 per month | 1.92 | 0.14 | 5.79 | (4.03) | 15.08 | |
| URGN | UroGen Pharma | 0.58 | 10 per month | 3.99 | 0.04 | 6.39 | (5.50) | 36.24 | |
| KOD | Kodiak Sciences | 0.15 | 24 per month | 4.12 | 0.11 | 10.04 | (6.87) | 25.07 | |
| TNDM | Tandem Diabetes Care | (0.02) | 8 per month | 2.94 | 0.10 | 7.03 | (4.34) | 27.14 | |
| BBOT | BridgeBio Oncology Therapeutics | (0.72) | 8 per month | 3.38 | 0.05 | 8.45 | (5.93) | 27.79 | |
| MNMD | Mind Medicine | (0.22) | 3 per month | 3.40 | 0.09 | 6.21 | (4.21) | 28.06 | |
| PHAT | Phathom Pharmaceuticals | 1.52 | 9 per month | 3.65 | 0 | 5.99 | (4.86) | 24.16 |
Pacira BioSciences Additional Predictive Modules
Most predictive techniques to examine Pacira price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacira using various technical indicators. When you analyze Pacira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pacira BioSciences Predictive Indicators
The successful prediction of Pacira BioSciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pacira BioSciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pacira BioSciences based on analysis of Pacira BioSciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pacira BioSciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pacira BioSciences's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 57.08 | 59.0 | 53.1 | 37.94 | PTB Ratio | 1.79 | 1.12 | 1.29 | 1.22 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.